Translate page

John Goldman: CML Treatment with imatinib

Please click on the image below to watch the webcast, and a window will open. You can then also click on the slides to jump to certain sections of the presentation. We appreciate your feedback: Please rate the video with the radio buttons above, share your comments using comments box below, or share your ideas in our Discussion Forum. View the other Virtual Education Program modules.

 

webcast-button
iv-goldman

Issues covered in this presentation:

  • Biology and mechanisms of CML
  • Mechanism of action of imatinib
  • Results of the IRIS study
  • Adverse effects of imatinib
  • Methods to detect residual disease
  • Imatinib in children and in pregnancy
 

 


Has this been helpful? Please provide your comments here:


Gilles Cousineau Community Builder Avatar   04.01.2011 (01:06:13)
CML Treatment with imatinib Yes No I am a French Canadian and 57 years old.In June 2005, I started Gleevec. Now, I am currently PCRU.
I adored the presentation of Dr. Goldman. In fact, I saw him at a conference at the Royal Victoria Hospital in Montreal with Dr. Pierre Laneuville. I loved the slideshow because it’s very clear and overall, a good introduction to CML.
I created a website which includes a lot of information on CML which includes links to the various presentations from iCMLf. My Website is at www.CMLeukemia.com.